Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Trastuzumab|DRUG: Oxaliplatin
Sponsor: SCRI Development Innovations, LLC
Collaborators: Sanofi